SEQUENCE OF HUMAN CARBOXYPEPTIDASE-D REVEALS IT TO BE A MEMBER OF THEREGULATORY CARBOXYPEPTIDASE FAMILY WITH 3 TANDEM ACTIVE-SITE DOMAINS

Citation
Fl. Tan et al., SEQUENCE OF HUMAN CARBOXYPEPTIDASE-D REVEALS IT TO BE A MEMBER OF THEREGULATORY CARBOXYPEPTIDASE FAMILY WITH 3 TANDEM ACTIVE-SITE DOMAINS, Biochemical journal, 327, 1997, pp. 81-87
Citations number
16
Categorie Soggetti
Biology
Journal title
ISSN journal
02646021
Volume
327
Year of publication
1997
Part
1
Pages
81 - 87
Database
ISI
SICI code
0264-6021(1997)327:<81:SOHCRI>2.0.ZU;2-5
Abstract
We have cloned the cDNA for human carboxypeptidase D (CPD), a new B-ty pe metallocarboxypeptidase that is membrane bound and has an acidic pH optimum. The 5.8 kb of cDNA sequenced contains an open reading frame of 4131 bp encoding 1377 amino acid residues. The sequence is similar (75% identity) to duck gp180, a protein that was isolated, cloned and sequenced as a hepatitis B virus-binding protein but not characterized as a carboxypeptidase. Hydropathic analysis revealed a hydrophobic re gion at the N-terminus, representing the signal peptide, and one near the C-terminus that probably represents the transmembrane anchor. The most striking feature is the presence of three tandem carboxypeptidase homology domains that have sequence similarity to the regulatory B-ty pe carboxypeptidase family, typified by carboxypeptidases M, E and N. Because of the three repeats, CPD is about three times larger (175-180 kDa) than other members of this family (approx. 50-62 kDa). Domain 2 is most closely related to carboxypeptidases M, E and N (45-48% identi ty), followed by domain 1 (37-38%) and domain 3 (20-27%), There is muc h higher sequence identity in regions containing putative active site residues, and all catalytically important residues are strictly conser ved in domains 1 and 2, In domain 3, however, only 1 of 8 active site residues is conserved, indicating that this portion might not be catal ytically active, Northern blotting of mRNA from human tissues and cell s showed high levels of CPD mRNA in placenta, pancreas and Hep G2 hepa toma cells, and smaller amounts in skeletal muscle, heart and HT-29 co lon carcinoma and melanoma cell lines.